M Ventures is the strategic, corporate venture capital fund of Merck KGaA, Darmstadt, Germany, investing in Biotechnology and Technology. They operate with dual strategic and financial objectives, targeting visionary companies that are innovating in healthcare drug development, life science tools, electronics, and frontier technology & sustainability. The fund seeks companies that develop new ways to treat challenging diseases, empower scientists with cutting-edge research and development tools, create novel solutions for information access, storage, processing, and display, and address complex challenges in sustainability and technology convergence. M Ventures takes an active role in its portfolio companies, partnering with entrepreneurs and co-investors to facilitate the translation of innovation into commercial success. They invest in companies targeting some of the most challenging diseases and disruptive tools and technologies for R&D as well as manufacturing within the Biotechnology sector. Furthermore, they are interested in companies creating the future of computing, data storage and display, sustainable solutions, and digital transformation within the Technology sector. The firm seeks to add significant business value on a monthly basis and is founder-friendly. They link scientific innovation to commercial strategy. M Ventures offers scientific and business insights relevant to startups.
Preferred startup development maturity for initial funding deployment.
Healthcare drug development, Life Science tools, Electronics, Frontier Technology & Sustainability
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...